Novo Nordisk accuses telehealth company Hims of 'deceptive marketing' and ends Wegovy partnership

scrippsnews.com/business/company-news/novo-nordisk-accuses-telehealth-company-hims-of-deceptive-marketing-and-ends-wegovy-partnership

Novo Nordisk has terminated its partnership with telehealth company Hims & Hers Health, accusing it of deceptively marketing weight-loss drugs.
The short-lived partnership, announced in April, allowed Hims & Hers to offer Wegovy — an FDA-approved medication for chronic weight management…

This story appeared on scrippsnews.com, 2025-06-24 21:34:47.038000.
The Entire Business World on a Single Page. Free to Use →